4-(4-Amino-3-chlorophenoxy)-7-methoxyquinoline-6-carboxamide, 97%, 250mg

2-(Chloromethyl)-3-fluoropyridine hydrochloride, 95.0%, 5g

Ácido 4-nitroantranílico, mínimo 98 %, para síntesis, 1 g, envase de vidrio

N-[6-(1-HYDROXY-1-METHYL-ETHYL)-2-(2-METHYLSULFONYLETHYL)INDAZOL-5-YL]-6-(TRIFLUOROMETHYL)PYRIDINE-2-CARBOXAMIDE, 95%, 250mg

8-Bromo-2-methyl-4,5-dihydronaphtho[1,2-d]oxazole, 97%, 100mg

6-chloro-1-(3,4-dichlorophenyl)-1-oxohexane, 97.0%, 1g

Methyl DL-2-(1-Boc-piperidin-4-yl)-beta-glycinate, 97.0%, 1g

7-chloro-2-ethyl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidine, 95%, 1g

Matraces de fondo redondo ROTILABO® con junta esmerilada, 10000 ml, 60/46, 1 Pieza

4-Bromo-N-(2-hydroxyethyl)benzenecarboxamide, 95.0%, 5g

5-Bromo-3-fluorobenzene-1,2-diamine, 95.0%, 10g

2-Chloropyrimidine-5-sulfonyl chloride, 95.0%, 250mg

4-Bromophenol>98.0%(GC)(T)100g